about
Vitamin D status in Bulgaria--winter data.Age and menopausal status affect osteoprotegerin and osteocalcin levels in women differently, irrespective of thyroid functionChanges in the prevalence of diabetes mellitus in bulgaria (2006-2012)Baseline Characteristics and Changes in Bone Mineral Density T-Scores of Bulgarian Women with Postmenopausal Osteoporosis Receiving Denosumab in Routine Clinical Practice.A study of the psychological status and sexuality in middle-aged Bulgarian women: significance of the hormone replacement therapy (HRT).Differences in the prevalence of vitamin D deficiency and hip fractures in nursing home residents and independently living elderly.Winter 25-hydroxyvitamin D levels in young urban adults are affected by smoking, body mass index and educational level.Increased Bone Mineral Density (Bmd) In Postmenopausal Women With Osteoporosis (Op) Receiving Two Denosumab Injections In Routine Clinical Practice In Bulgaria.Femoral neck bone mineral density and 10-year absolute fracture risk in a national representative sample of Bulgarian women aged 50 years and older.Male gender differences in the thyroid ultrasound features, thyroid peroxidase antibodies and thyroid hormone levels: a large population-based study.The prevalence of the metabolic syndrome increases through the quartiles of thyroid stimulating hormone in a population-based sample of euthyroid subjects.Effects of tibolone on body composition in postmenopausal women: a 1-year follow up study.Increased prevalence of depression and anxiety among subjects with metabolic syndrome and known type 2 diabetes mellitus - a population-based study.Influence of serum levels of thyroid-stimulating hormone and anti-thyroid peroxidase antibodies, age and gender on depression as measured by the Zung Self-Rating Depression Scale.Medication-taking behaviour in Bulgarian women with postmenopausal osteoporosis treated with denosumab or monthly oral bisphosphonates.[Bone density measurement: quantitative ultrasound of the calcaneus and distal radius. A comparison with dual spectrum X-ray absorptiometry]Individual risk factors of the metabolic syndrome in adult patients with growth hormone deficiency--a cross-sectional case-control study
P50
Q30606501-6A9A1B00-568B-48AE-A8E2-54FCB7D6C8C3Q34016508-1C43024C-EB17-4A25-9F7E-9957CED38559Q35605846-9D55BDD7-89EA-4AF7-9D9B-401A9DA580C7Q37653413-D2966633-815F-4FAA-B6A9-D85B5B6016FAQ39577128-086484CA-C250-4781-8722-28F4E8A20B64Q39972378-8AB03870-E095-44F1-A335-F0FD60896B52Q40214507-AFBEFDE9-E81A-4FDE-8636-D114ADE4004DQ43926809-45A59BA5-6EAC-4672-856F-AF0DE1CF3776Q43927329-EEADAEF2-7B56-4E81-AFE5-80B0EC54BAEFQ44192128-61D262D3-594A-4D30-BEC8-B022C26CB22DQ44622301-F9AB0266-219C-4733-8EDF-20C38BD0A083Q46614921-4124F7E2-BB29-4145-8EF4-B7A077355BE1Q47571701-F7488423-4094-4EFA-9B9A-3330D360FD51Q48297805-073DB429-C3D9-4F0F-9E9A-66A751BA7D61Q49630595-629EEBCE-EF2B-4F28-B0F0-76C47764CF80Q80179414-8A9C9755-AD8C-4794-8FEE-69CA4981FE08Q86028752-525D37C0-598B-49BF-8CFD-5FC0D59A5C5A
P50
description
researcher ORCID ID = 0000-0002-9203-4149
@en
name
Alexander Shinkov
@ast
Alexander Shinkov
@en
Alexander Shinkov
@es
Alexander Shinkov
@nl
type
label
Alexander Shinkov
@ast
Alexander Shinkov
@en
Alexander Shinkov
@es
Alexander Shinkov
@nl
prefLabel
Alexander Shinkov
@ast
Alexander Shinkov
@en
Alexander Shinkov
@es
Alexander Shinkov
@nl
P1153
25422853300
P31
P496
0000-0002-9203-4149